Title: Habitual implantation failure /RM,RIF/
1Habitual implantation failure /RM,RIF/
2Successful implantation
- Materno-fetal dialogue
- Competent blastocyst
- receptive endometrium
3Window of implantation
Th1 phenomenon
- 19-23 cycle day (6. day after ovulation!!!)
- Stromal cells transformation into decidual cells
secretory granules, pinopodes, disappearance of
mycrovilli - Cytokines, chemokines, ligands.
- dNK, macrophages, uDCs
Regulatory role in trophoblast invasion
APC antigen presenting cells
Angiogenesis, decidualisation
4LIF and p53 (Stewart LC, Nature 2007 450619,
Hu W et al. Nature 2007 450721)
HCG LIF
LIF receptor interraction endometrial
receptivity
Acquisition of adhaesion ligands and loss of
inhibitory molecules
5HOX gens
Segmental body identity
- HOX gens endometrial development
- - steroid hormones
function - - elevated expression
during secretory phase - - with successful
implantation increased
decidual expression - - regulation of
morphological parameters of implantation window
pinopodes, beta 3 integrin, IGFBP1 - - essential for
implantation low HOX genes expression during
the secretory phase - infertility /Taylor et
al.1999, Rackow and Taylor 2010/
unexplained infertility /Brosens et al., 2009/
6HOX expression manipulation- increased
implantation with EAI /in vitro / /Bagot et
al., 2000/
7Implantation failure/Cakmak H, Taylor HS. 2011/
- Leiomyoma
- deformity
- occlusion
- Low HOXA10 and BTEB1 exp.
- PCOS
- Decreased avß3 integrin, HOXA-10 and IGFBP-1
- Overexpression of androgene receptors
- Absence of estrogen receptor-a downregulation
during implantation window - Overexpression of steroid receptor coactivators
- AIB1 and TIF2
- Endometrial polyp
- Gamete transport
- Decreased IGFBP-1 i osteopontin
- Low progesteron receptors
8Implantation failure /Cakmak H, Taylor HS. 2011/
- Endometriosis
- - Decreased avß3 integrins and LIF
- - Low IL-11 and IL-11R
- - Absence of HOXA10 and HOXA11 increase
- - Elevated EMX2
- - Progesteron resistence
- - Disregulation of PR-A / PR-B
- - HOX 10 promotor hypermetilation
- Hydrosalpinx
- Toxic effect of tubal secretions
- Decrease of avß3 integrin and LIF-a
- Low HOXA10 expression
- Septum, arcuatus
- Sy Asherman
- Thin endometrium
- Ovarian stimulation
- Adiposity
- Trombophilia
- Impaired endometrial function
- Immunologic factors
9ENDOMETRIOSIS
10Hox10/HOX10 geni ECTOPIC AND EUTOPIC
ENDOMETRIUM /Zanatta et. al., 2010/
Hoxa 9-tubes Hoxa 11-cervix Hoxa 13-vagina
Mulleriosis 11 female fetuses !!!!!!
HOX10-epithelial, stromal and myometrial
embriogenesis Expression is regulated by
cyclical E/P variation Endometrial receptivity
and nidation window
- Embrional remnants regrowth during and after
puberty - De novo creation of eutopic or ectopic
endometrium when, why, what is the initial
stimulus ????
11EAI /Zanatta et. Al., 2010/
In 50 no alfa 5 beta 3 integrin - Infertile
with mild endometriosis /M. Donaghay, B.A. Lessey
2007/
Low FC, abnormal follicular maturation, Low
oocyte quality /Toya et al. 2000/
- Low endometrial alfa, beta integrin
- No IL -11 i IL 11R i LIF-a
- After GNRH analogues or ablation
- increased HOX expression and
- integrins
- /Lessey i Young 1997, Daftary et al., 2007/
- - Poor oocyte quality
- - Implantation failure
Ectopic towards eutopic endometrium -
communication ? Could radical surgery of
ectopic endometrium assure normal eutopic
edometrium function
12Molecular differences
- Ectopic
- 17beta-hydroxsteroid d., aromatase, P
rec., ERbeta 140x - P rezistence
-
- apoA-I plasma, endometrium, HCG resistant
/beta HCG can not inhibit apo A-I/Brosens et al.,
2009/
hallmark of e.
Medical od radical surgical silencing of
extrauterine genes could PREVENT e. Radical
surgery of e.foci DOUBLED success in ART cycles
/Bianchi et al., 2009/
13HYDROSALPINXENDOMETRITIS CHR
14PID , hydrosalpinx /Chukwuemeka et al, 2002/
- Chl. inf. , PID
- endometritis
- HSP- scar tissue
-
- - anti Chl HSP IgA marker for unsuccessful
IVF - - HSP 10 tubal infertility
- - HSP 60- early misccariage
- Hydrosalpinx
- ?Flushing effect, pinopod malfunction,
malfunction of endometrial epitelial cells. - ?Embriotoxic /animal studies/
- ?Out of phase endometrium low integrins , LIF,
HOX
IVF success after salpingectomy / Strandel et
al., 2001, Cochrane dtb2002 /
15FIBROIDS
16IVF/ICSI meta analysis /Bajekal , Li 2000/
- Compared to infertile
- SM decreased fertility
- /RR PR 0,30/
- /Somigliana et al. 2011/
Similar results 3 META ANALYSES Pritts et al,
2009 Sunkara et al, 2010 Metwally et al, 2011.
P lt0,05
17The effect of submucous fibroids /Rackow and
Taylor, 2010/
- Decreased HOXA10, HOXA11, LIF, BTEB1
- MRNA HOXA 10 i HOXA 11
compared to intramural - Global entire endometrium, not only beneath
myoma - Size of myoma not important!!!!!
Glycodelin, IL-10 only with SM /Ben-Nagi J et
al., 2010/
18Inflammatory reaction with fibroids/Miura S et
al., 2006/
- Monocyte chemotactic protein (MCP-1),
macrophage infiltration, PGF2alfa - SM and IM
sigg. elevated compared to SSM, healthy
myometrium or endometrium - Size of myoma not important!!!!!
19The outcome of pregnancy with fibroidsUniv. Med.
School Zagreb 2008-2012, N135mean age 35,4 y.
Skrablin et al. Eur J Obstet Gynecol Reprod Biol.
2005118(1)115-6.
Ap.1.9,1 Ap.2.9,4 pH 7,26
- 17 previous myomectomy17,6
- 35 previous delivery 25, 9
- 84 first pregnancy 62, 2
- 22 previous misccariage 16, 2
- IVF 9 (6,6)
Vaginal delivery 39 (28, 8) Complications 6
(4, 4) Ruptura uteri completa 1 Hysterectomia
abd. 5
N newborns gt22 tj 134 (1 triplets , 1
twins) Perinatal mortality 1/134 7,4o 23
weeks, Apgar 1/0
20The ooutcome of pregnancy after myomectomy Univ.
Med. school Zagreb 2008-2012, N50mean age 35,9
y.
Skrablin et al.. Successful pregnancy after
spontaneous rupture of scarred uterus following
fundal myomectomy. Eur J Obstet Gynecol Reprod
Biol. 2005121(2)251-2
N 52 newborns (3 twins) Perinatal
mortality 3/52 57,6o (26 gemin 31 ruptura 32
IUGR)
- 15 previous birth 30,0
- 27 first pregnancy 54,0
- 9 previous miscarriage 18,0
- 3 IVF 6
Technique 18 lap 36,0 26 LPSC 52,0 2 Hys
4 1 sc 2 1 conversion lpsc to lap 2 2?
Ap.1.8,7 Ap.29,1 pH 7,16
Vaginal birth 4 Complications 1 (2,
0) Ruptura uteri completa 1 (31 tj., mors fetus
in grav)
21The effect of myomectomy
SM
- PCT spontaneous pregnancies
- - 15 increase in fertility, outcome of
pregnancy unknown /Casini ML et al., 2006/ - - 10 reports risk of complications after
myomectomy can not be determined with certainty - /Viswanathan et al., 2007/
22The effect of myomectomy randomized matched
controlstudy/Shokeir T, et al. 2010/
SM
Hys miomectomy N 101
Hys biopsy N103
63,4
28,2
pregnancy
Success with op. with type O and I, but NOT with
myoma type II
23The effect of myomectomy /Pritts EA, Parker WH,
Olive DL, 2009/
IM
- IM N RR
p - (studies)
- CPR 2 3,76
n.s. - LBR 1 1,67
n.s. - SA 1 0,76
n.s. -
..as yet no data to support myomectomy in the
treatment of IM myomas to improve fertility
outcome
24Tulandi, Barbieri, Falk, Uptodate 2011
- Asymptomatic leiomyomas
-
- - Suggestion not to postpone pregnancy,
since leiomyomas, combined with advanced maternal
age, may impair fertility and adversely impact
pregnancy (Grade 2C) - - Suggestion not to perform prophylactic
myomectomy to prevent pregnancy
complications (Grade 2C) - Infertile or a history of recurrent pregnancy
loss -
- - Submucosal or an intracavitary component
- myomectomy (Grade 2C). - - Subserosal - against myomectomy (Grade
2C). - - Intramural fibroids that do not distort
the uterine cavity, other sources of infertility
should be addressed. The decision to perform a
myomectomy should be made based on patient
preference and clinical factors (eg, obstructing
of a fallopian tube or the cervical canal or
failure of other infertility treatments). - IVF
- Submucosal fibroid or an intramural fibroid that
deforms the uterine cavity should be removed
(Grade 2C).
25ENDOMETRIAL POLYP
26Implantation with endometrial polyp
- Low IGFBP1 and osteopontin
- Low P receptor expression P resistency
- After polypectomy elevation of IGFBP1,
osteopontin levels /Ben-Nagy et al., 2009/
27The effect of polypectomy in subfertile women
S - IVF/ICSI/IUI Polipectomy C -IVF/ICSI/IUI
Without polipectomy
- Polyps
- - prior to IVF
- should be removed
- during the course of COH-
- management individualized
- /Afifi K, et al., 2010/
The only randomized
Perez-Medina et al.2005 IUI randomizirana
Lass et al.1999
Isikoglu et al.2006
28Septum uteri /Revel, 2012/
- Blood flow dearranged
- UTERUS ARCUATUS - less than 1 cm, - probably
without ill effect - Hys - simple
- Still dubious whether to perform op. before
conception - Peer opinion poll in support of prophylactic
operation less than 50 of experts!!!! /M.J.
Cohen, T.S. Rosenzweig, A. Revel, 2007/
29Asherman Sy
- Sperm transport or implantation compromised
- Infertility in 802 / 2151 (43)- depending on
severity - PR no
operation 51 (540 of 1052),
- no therapy 46 (133 of 292) - - Hys 74
(468 of 632) - /J.G.
Schenker, E.J. Margalioth 1982/ - After surgery IUD ili baloons
- Bone marrow stem cells - regeneration /H.S.
Taylor 2004/
30Thin endometrium
- Problem elevated oxygen in endometrium /R.F.
Casper 2011/ - But, implantation could be successful even with
very thin endometrium /3.7 mm/J.H. Check, R.
Cohen 2011/ - 3D endometrial volum compared to 2D endometrial
thickness - not better for IVF success
estimation /J. Alcazar 2006/
31Ovarian stimulation
- E elevation endometrial receptivivity
decreased - CPR per transfer sigg. better after transfer of
frozen embria /B.S. Shapiro et al., 2011/
32PCOS
33PCOS
- Oligoovulation
- P low and its regulatory function dearranged,
constant unopposed E2 - Low alfa and beta integrin, HOX-10 i IGFBP1
during secretory phase even in those with
ovulations - Elevated androgens - decreased HOX 10 expression
- Elevated A receptors, no downregulatiom Ealfa
receptors
Low receptivity and steroid receptor
disregulation The consequence of low P or
insulin/androgen imbalance? /Cakmak H, Taylor HS,
2011/
34ENDOMETRAL EVALUATION
- Clinical
- US thicknes and texture - 6mm
- No correlation with hystology
- Proliferative phase defect
- Subendometrial blood flow no correlation with
implantation success or failure - SHG
- In general capability of US methods to
estimate implantation is low /Cakmak H i Taylor
Hs, 2011/ - Hys
- PHD
- Endometrial dating no criteria for window of
implantation - Difficult and unpredictable in stimulated cycles
- Cannot differentiate fertile from infertile
population /Coutifaris i sur. 2004/ - Markers
- - p53 /Goodman et al., 2009/
- - gene profiling /microarray/ or proteomic
analysis- apoA-I /Brosens et al., 2011/ - - alfa, beta integrin, mucin, LIF, HOXA10,
endometrial function test-EFT ..still
experimental /Dubowy i sur. 2003/ - - trombophilia
-
MRI-junctional zone
35 LIF and IL 11
- Uterine flushings
- - LIF levels - estimation of successful
implantation in IVF /Makkar et al., 2006/ - - low levels in infertile women /Delage
et al., 1995/ -
- - LH 2 can predict IVF success in the
next cycle /Mikolajzyk et al. 2007/ - FUTURE estrimation of endometrial function
before aspiration - IL 11mRNA - low levels in trophoblast and plasma
in anembrionic gestation or miscarriage
/Koumantaki et al., 2001/
Therapy??? /Brinsden et al 2009/
36Treatment - today
- Endometriosis
- Fibroid
- Polyp
- Hydrosalpinx
- PCOS
- Adenomyosis
- Endometritis
- Trombophilia
- - Ablation, GNRH agonists
- - Miomectomy
- - Polypectomy
- - Salpingectomy or tubal
- occlusion
- - Weight loss, metformin
- - GNRH agonists, surgery
-
- -Antibiotics
- - LMWH
Heparin, aspirin vaskularization Cortikosteroids
immunological tolerance LIF, progesteron
receptivity IG immunologic tolerance
37Treatment tomorrow.
- Reproductive surgery
- Endometrial scratching /Barash A et al., 2003/
- Priming - locally instilation or parenteral
granulocyte colony-stimulating factor, HCG or
piroxicam /N. Gleicher et al., 2011, R. Mansour
et al., 2011, H.S. Moon et al., 2004/ - Stem cells /Taylor HS, 2004, Du H, Taylor
HS,2010/ - Heparin, metformin stimulation of gene
expression in endometrium /Germeyer et al., 2011/ - Embryo culture with adhaesion promoting factors (
hyaluronic acid, heparanase, VEGF) / Revel et
al., 2005, Hannan NJ et al., 2011/ - PIF /Duzy K., et al., 2011/
- ..
Leukonorm Lenograstim .
Gene improvement
Immunomodulation